Jeffrey A Meckler's Net Worth

$429 Thousand

Estimate Recalculated Jun 7, 2024 04:08PM EST

Who is Jeffrey A Meckler?

Jeffrey A Meckler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., SURMODICS INC, Intec Pharma Ltd., Indaptus Therapeutics, Inc., Cocrystal Pharma, Inc., and QLT INC/BC.

SEC CIK

Jeffrey A Meckler's CIK is 0001506916

Past Insider Trading and Trends

2014 was Jeffrey A Meckler's most active year for acquiring shares with 10 total transactions. Jeffrey A Meckler's most active month to acquire stocks was the month of April. 2015 was Jeffrey A Meckler's most active year for disposing of shares, totalling 4 transactions. Jeffrey A Meckler's most active month to dispose stocks was the month of May. 2013 saw Jeffrey A Meckler paying a total of $290,000.00 for 304,500 shares, this is the most they've acquired in one year. In 2015 Jeffrey A Meckler cashed out on 35,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Travere Therapeutics, Inc. (TVTX) Snapshot price: $8.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.72%
6.5K
—
—
81K
May 8
Form 4
+6.43%
4.5K
—
—
74.5K
May 17
Form 4
+4.48%
3K
—
—
70K
May 11
Form 4
+4.69%
3K
—
—
67K
May 14
Form 4
+4.92%
3K
—
—
64K
May 15
Form 4
+3.39%
2K
—
—
61K
May 8
Form 4
+4.42%
2.5K
—
—
59K
May 9
Form 4
+4.63%
2.5K
—
—
56.5K
May 17
Form 4
+3.85%
2K
—
—
54K
May 18
Form 4
+10.64%
5K
$15.31
$76,564.50
52K
Mar 4
Form 4
+27.03%
10K
$14.45
$144,500.00
47K
Mar 3
Form 4
+5.71%
2K
—
—
37K
Jun 8
Form 4
+75.00%
15K
$8.60
$129,049.50
35K
Nov 25
Form 4
∞
20K
—
—
20K
Oct 8
Form 3
—
0
—
—
0
No matching records found

SURMODICS INC (SRDX) Snapshot price: $30.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Intec Pharma Ltd. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 15
Form 4
+11.31%
20K
$0.68
$13,620.00
196.76K
Aug 28
Form 4
+130.27%
100K
$0.46
$45,700.00
176.76K
Aug 23
Form 4
—
0
—
—
0
Apr 4
Form 3
—
0
—
—
0
No matching records found

Indaptus Therapeutics, Inc. (INDP) Snapshot price: $1.66

CEO and Director

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Jan 18
Form 4
+15.30%
10K
$1.89
$18,945.48
75.37K
Nov 18 - Nov 21
Form 4
+18.72%
10.31K
$2.80
$28,862.40
65.37K
Sep 8
Form 4
+21.36%
9.69K
$2.56
$24,770.64
55.07K
Sep 6 - Sep 7
Form 4
+76.92%
19.73K
$2.63
$51,882.01
45.37K
Jun 6
Form 3
—
0
—
—
0
No matching records found

Cocrystal Pharma, Inc. (COCP) Snapshot price: $1.59

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+81.01%
294.12K
$0.51
$150,000.18
657.16K
Mar 15
Form 4
+38.02%
100K
$0.58
$57,870.00
363.04K
Dec 23
Form 4
—
0
—
—
0
Oct 1
Form 4
+163.04%
163.04K
$0.92
$149,999.56
263.04K
Mar 25
Form 4
—
0
—
—
0
Mar 23
Form 4
∞
100K
$0.46
$45,610.00
100K
Dec 11
Form 3
—
0
—
—
0
No matching records found